Back to Search
Start Over
Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.
- Source :
-
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2011 May; Vol. 55 (5), pp. 2478-80. Date of Electronic Publication: 2011 Mar 14. - Publication Year :
- 2011
-
Abstract
- Candida empyema is a serious complication of disseminated candidiasis. However, little is known about the intrapleural pharmacokinetics of echinocandins. We report the penetration of anidulafungin into the pleural fluid of a patient with Candida tropicalis empyema. The anidulafungin ratio for the area under the concentration-time curve from 0 h to the last measurement between pleural fluid and serum values was only 0.125 (12.5%), with pleural fluid concentrations ranging between 0.67 and 0.88 μg/ml.
- Subjects :
- Adult
Anidulafungin
Empyema, Pleural drug therapy
Empyema, Pleural microbiology
Humans
Male
Antifungal Agents pharmacokinetics
Antifungal Agents therapeutic use
Candida drug effects
Candida pathogenicity
Echinocandins pharmacokinetics
Echinocandins therapeutic use
Empyema drug therapy
Empyema microbiology
Subjects
Details
- Language :
- English
- ISSN :
- 1098-6596
- Volume :
- 55
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Antimicrobial agents and chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 21402857
- Full Text :
- https://doi.org/10.1128/AAC.01560-10